A Trial to Evaluate Natural Orifice Transgastric Endoscopic Cholecystectomy With Laparoscopic Assistance
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00979186
Recruitment Status :
(Study Terminated - No enrollment, business decision.)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Men and women will be enrolled in this study who:
Are willing to give consent and comply with evaluation and treatment schedule, able to understand and complete study questionnaires;
At least 18 years of age;
Have a clinical diagnosis of gallbladder disease indicated for cholecystectomy;
ASA Classification I or II (Appendix II); and
Have a negative serum pregnancy test (for women of childbearing potential);
Have the study procedure attempted.
BMI > 35;
Use of immunosuppressive medications (within 6 months of surgery; single burst dosages and inhalable steroids are acceptable);
Suspicion of gallbladder cancer, tumor, polyps, or mass;
Acute cholecystitis or acute pancreatitis;
Presence of common bile duct stones;
History of open abdominal surgery;
Evidence of abdominal abscess or mass;
Use of anticoagulants or anti-platelet agents (use of daily cardio protective doses of aspirin, up to 81 mg/day, is acceptable and shall not constitute an exclusion criterion) or the presence of coagulopathy;
Clinical diagnosis of sepsis;
History of peritoneal trauma;
Co-morbid condition(s) that could limit the subject's ability to participate in the study or to comply with follow-up requirements, or that could impact the scientific integrity of the trial;
Planned concurrent surgical procedure;
Prior or planned major surgical procedure within 30 days before or after study procedure;
Previous diagnosis of intra-abdominal adhesions;
Participation in any other investigational device or drug trial that has not completed the primary endpoint or that clinically interferes with the current study endpoints;
Previously enrolled in the current series of 4 trials investigating the EES NOTES GEN1 Toolbox; or
Any condition which precludes compliance with the study (Investigator discretion).